IBUPROFEN AND FAMOTIDINE

N/A

Manufactured by Ascend Laboratories, LLC

108 FDA adverse event reports analyzed

Last updated: 2026-04-15

About IBUPROFEN AND FAMOTIDINE

IBUPROFEN AND FAMOTIDINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Ascend Laboratories, LLC. The most commonly reported adverse reactions for IBUPROFEN AND FAMOTIDINE include ARTHRALGIA, PAIN, ALOPECIA, DRUG INEFFECTIVE, RASH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for IBUPROFEN AND FAMOTIDINE.

Top Adverse Reactions

ARTHRALGIA3 reports
PAIN3 reports
ALOPECIA2 reports
DRUG INEFFECTIVE2 reports
RASH2 reports
WHEEZING2 reports
ABDOMINAL DISCOMFORT1 reports
ABDOMINAL DISTENSION1 reports
ANXIETY1 reports
AVIAN INFLUENZA1 reports
BACK DISORDER1 reports
BACK PAIN1 reports
BLOOD CHOLESTEROL ABNORMAL1 reports
BLOOD CREATININE INCREASED1 reports
BLOOD PRESSURE ABNORMAL1 reports
BURSA DISORDER1 reports
C REACTIVE PROTEIN INCREASED1 reports
CEREBELLAR TONSILLAR ECTOPIA1 reports
COLITIS1 reports
CONCOMITANT DISEASE AGGRAVATED1 reports
COUGH1 reports
COVID 191 reports
DACTYLITIS1 reports
DEAFNESS NEUROSENSORY1 reports
DERMATOPATHIC LYMPHADENOPATHY1 reports
DIARRHOEA1 reports
DISCOMFORT1 reports
DIZZINESS1 reports
DRUG EFFECTIVE FOR UNAPPROVED INDICATION1 reports
DRY EYE1 reports
DYSGEUSIA1 reports
DYSPNOEA1 reports
EAR DISCOMFORT1 reports
EAR INFECTION1 reports
ECONOMIC PROBLEM1 reports
EMOTIONAL DISTRESS1 reports
ENTHESOPATHY1 reports
EXPIRED PRODUCT ADMINISTERED1 reports
EYE PAIN1 reports
EYE PRURITUS1 reports
EYELID DISORDER1 reports
FATIGUE1 reports
GASTRIC ULCER1 reports
GASTROOESOPHAGEAL REFLUX DISEASE1 reports
H1N1 INFLUENZA1 reports
HEAD DISCOMFORT1 reports
HEADACHE1 reports
HOSPITALISATION1 reports
HOT FLUSH1 reports
IMPAIRED QUALITY OF LIFE1 reports
INITIAL INSOMNIA1 reports
INJURY1 reports
INTENTIONAL DOSE OMISSION1 reports
INTENTIONAL PRODUCT MISUSE1 reports
INTENTIONAL PRODUCT USE ISSUE1 reports
JOINT STIFFNESS1 reports
JOINT SWELLING1 reports
LACRIMATION INCREASED1 reports
LEIOMYOMA1 reports
LOW DENSITY LIPOPROTEIN INCREASED1 reports
LUMBAR FLEXION SYNDROME1 reports
LUNG DISORDER1 reports
MUSCLE OEDEMA1 reports
MUSCLE SPASMS1 reports
MYALGIA1 reports
MYELOPATHY1 reports
NASAL CONGESTION1 reports
NASOPHARYNGITIS1 reports
NAUSEA1 reports
NEURALGIA1 reports
NIGHT SWEATS1 reports
OBESITY1 reports
ORAL HERPES1 reports
OSTEOARTHRITIS1 reports
OXYGEN SATURATION ABNORMAL1 reports
PAIN IN EXTREMITY1 reports
PARAESTHESIA1 reports
PHYSICAL DISABILITY1 reports
PLATELET DISORDER1 reports
PNEUMOTHORAX1 reports
PROCEDURAL PAIN1 reports
PRODUCT ADMINISTRATION INTERRUPTED1 reports
PRODUCT QUALITY ISSUE1 reports
PRODUCT USE IN UNAPPROVED INDICATION1 reports
PRURITUS1 reports
PSORIASIS1 reports
PSORIATIC ARTHROPATHY1 reports
RADICULOPATHY1 reports
RECTAL HAEMORRHAGE1 reports
RESPIRATORY SYNCYTIAL VIRUS INFECTION1 reports
RESTLESS LEGS SYNDROME1 reports
RESTLESSNESS1 reports
RHINITIS1 reports
SCIATICA1 reports
SLEEP DISORDER1 reports
SPINAL OSTEOARTHRITIS1 reports
STRESS1 reports
SYRINGOMYELIA1 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE1 reports
TINNITUS1 reports

Report Outcomes

Out of 9 classified reports for IBUPROFEN AND FAMOTIDINE:

Serious 66.7%Non-Serious 33.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female7 (77.8%)
Male2 (22.2%)

Reports by Age

Age 311 reports
Age 521 reports
Age 611 reports
Age 621 reports
Age 641 reports
Age 751 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with IBUPROFEN AND FAMOTIDINE?

This profile reflects 108 FDA FAERS reports that mention IBUPROFEN AND FAMOTIDINE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for IBUPROFEN AND FAMOTIDINE?

Frequently reported terms in FAERS include ARTHRALGIA, PAIN, ALOPECIA, DRUG INEFFECTIVE, RASH, WHEEZING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures IBUPROFEN AND FAMOTIDINE?

Labeling and FAERS entries often list Ascend Laboratories, LLC in connection with IBUPROFEN AND FAMOTIDINE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.